Capital Fund Management S.A. Grows Stake in Progyny, Inc. (NASDAQ:PGNY)

Capital Fund Management S.A. lifted its holdings in shares of Progyny, Inc. (NASDAQ:PGNY) by 147.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 199,136 shares of the company’s stock after acquiring an additional 118,604 shares during the quarter. Capital Fund Management S.A.’s holdings in Progyny were worth $3,435,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. F M Investments LLC lifted its position in shares of Progyny by 13.0% in the 4th quarter. F M Investments LLC now owns 20,420 shares of the company’s stock worth $352,000 after purchasing an additional 2,342 shares during the period. CenterBook Partners LP bought a new stake in Progyny during the 4th quarter valued at approximately $1,593,000. Invesco Ltd. grew its holdings in shares of Progyny by 2.9% during the 4th quarter. Invesco Ltd. now owns 274,819 shares of the company’s stock worth $4,741,000 after acquiring an additional 7,845 shares during the period. Cerity Partners LLC bought a new position in shares of Progyny in the 4th quarter worth approximately $229,000. Finally, Aristides Capital LLC purchased a new position in shares of Progyny in the 4th quarter valued at approximately $245,000. Hedge funds and other institutional investors own 94.93% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the company. Bank of America upped their price target on Progyny from $21.00 to $25.00 and gave the stock a “buy” rating in a research note on Tuesday, February 11th. BTIG Research upgraded shares of Progyny from a “neutral” rating to a “buy” rating and set a $28.00 price target for the company in a research note on Monday, March 31st. JPMorgan Chase & Co. lifted their price target on shares of Progyny from $17.00 to $23.00 and gave the company a “neutral” rating in a research report on Tuesday, January 28th. Finally, Canaccord Genuity Group upped their price objective on shares of Progyny from $17.00 to $23.00 and gave the stock a “hold” rating in a report on Friday, February 28th. Eight analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat, Progyny currently has a consensus rating of “Hold” and a consensus price target of $23.64.

Progyny Trading Up 0.4 %

Shares of PGNY opened at $22.34 on Monday. Progyny, Inc. has a 12 month low of $13.39 and a 12 month high of $34.40. The business’s fifty day simple moving average is $22.01 and its two-hundred day simple moving average is $18.70. The company has a market cap of $1.91 billion, a price-to-earnings ratio of 38.52, a P/E/G ratio of 2.39 and a beta of 1.33.

Progyny Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.